Baseline fibroblast growth factor 23 predicts incident heart failure and cardiovascular mortality in patients with chronic kidney disease: A 3-year follow-up study
In CKD patients with preserved EF, serum iFGF23 was elevated before LVEF declined. A higher baseline serum iFGF23 level is significantly associated with the incidence of HF and cardiovascular mortality over a 3-year follow-up, demonstrating independent and incremental predictive value beyond traditional risk factors.
Authors
- Danhui Li (ORCID: https://orcid.org/0000-0003-3218-1961)
- Yonggui Wu (ORCID: https://orcid.org/0000-0001-6434-4759)
- Jintun Zhang (ORCID: https://orcid.org/0000-0002-3163-6808)
- Xiangjie Yang
- Xinyuan Zhou (ORCID: https://orcid.org/0000-0002-1374-8240)
- Renwu Zhou (ORCID: https://orcid.org/0000-0003-1773-7095)
- Dingxin Zhang (ORCID: https://orcid.org/0000-0002-8089-6040)
- Xiaoxia Wang (ORCID: https://orcid.org/0000-0002-5687-4992)
- Yuxin Jiang (ORCID: https://orcid.org/0000-0002-8388-7262)
- Ying Wang (ORCID: https://orcid.org/0000-0002-1784-7465)
Institutions
- Anhui Medical University (CN)
- First Affiliated Hospital of Anhui Medical University (CN)
Publication Details
- Journal
- IJC Heart & Vasculature
- Published
- 2024-12-24
- DOI
- https://doi.org/10.1016/j.ijcha.2024.101587
- Citations
- 3
- Primary Topic
- Parathyroid Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.02
Funders
- Anhui Medical University